These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 20460919

  • 1. Animal models of non-alcoholic steatohepatitis: of mice and man.
    Schattenberg JM, Galle PR.
    Dig Dis; 2010; 28(1):247-54. PubMed ID: 20460919
    [Abstract] [Full Text] [Related]

  • 2. Animal models of NASH: getting both pathology and metabolic context right.
    Larter CZ, Yeh MM.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1635-48. PubMed ID: 18752564
    [Abstract] [Full Text] [Related]

  • 3. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 4. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 5. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new?
    Ariz U, Mato JM, Lu SC, Martínez Chantar ML.
    Methods Mol Biol; 2010 Jan; 593():109-36. PubMed ID: 19957147
    [Abstract] [Full Text] [Related]

  • 7. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
    Yamazaki Y, Kakizaki S, Takizawa D, Ichikawa T, Sato K, Takagi H, Mori M.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
    [Abstract] [Full Text] [Related]

  • 8. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L, Forgione A, Gasbarrini G, Grieco A.
    Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
    [Abstract] [Full Text] [Related]

  • 9. Commonly used animal models of non-alcoholic steatohepatitis.
    Fan JG, Qiao L.
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):233-40. PubMed ID: 19502161
    [Abstract] [Full Text] [Related]

  • 10. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice.
    Wouters K, van Bilsen M, van Gorp PJ, Bieghs V, Lütjohann D, Kerksiek A, Staels B, Hofker MH, Shiri-Sverdlov R.
    FEBS Lett; 2010 Mar 05; 584(5):1001-5. PubMed ID: 20114046
    [Abstract] [Full Text] [Related]

  • 11. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr 05; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 12. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN, Tao RY, Tian JY, Liu GT, Ye F.
    Life Sci; 2008 May 07; 82(19-20):983-90. PubMed ID: 18417155
    [Abstract] [Full Text] [Related]

  • 13. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.
    J Gastroenterol Hepatol; 2008 Feb 07; 23(2):267-75. PubMed ID: 17868330
    [Abstract] [Full Text] [Related]

  • 14. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM.
    J Hepatol; 2004 Oct 07; 41(4):592-8. PubMed ID: 15464239
    [Abstract] [Full Text] [Related]

  • 15. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul 07; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 16. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H, Eivindson MV, Hamilton-Dutoit S, Vilstrup H.
    Ugeskr Laeger; 2003 Mar 10; 165(11):1115-8. PubMed ID: 12677985
    [Abstract] [Full Text] [Related]

  • 17. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
    Rangnekar AS, Lammert F, Igolnikov A, Green RM.
    Liver Int; 2006 Oct 10; 26(8):1000-5. PubMed ID: 16953841
    [Abstract] [Full Text] [Related]

  • 18. Hepatic microcirculation in fatty liver disease.
    Farrell GC, Teoh NC, McCuskey RS.
    Anat Rec (Hoboken); 2008 Jun 10; 291(6):684-92. PubMed ID: 18484615
    [Abstract] [Full Text] [Related]

  • 19. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A.
    Eur Rev Med Pharmacol Sci; 2005 Jun 10; 9(5):273-7. PubMed ID: 16231589
    [Abstract] [Full Text] [Related]

  • 20. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec 10; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.